Dexamethasone palmitate

Dexamethasone palmitate (DXP) is a proagent of Dexamethasone (HY-14648) . Dexamethasone palmitate can be used for the research of inflammation[1][2].

Product Specifications

CAS Number

[14899-36-6]

Product Name Alternative

DXP

UNSPSC

12352211

Hazard Statement

H302

Target

Drug Intermediate

Type

Reference compound

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Endocrinology

Assay Protocol

https://www.medchemexpress.com/dexamethasone-palmitate.html

Purity

99.68

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

C[C@@]12[C@](C[C@@H](C)[C@]2(O)C(COC(CCCCCCCCCCCCCCC)=O)=O)([H])[C@@]3([H])[C@@](F)([C@@]4(C(CC3)=CC(C=C4)=O)C)[C@@H](O)C1

Molecular Formula

C38H59FO6

Molecular Weight

630.87

Precautions

H302

References & Citations

[1]Lorscheider M, et al. Dexamethasone palmitate nanoparticles: An efficient treatment for rheumatoid arthritis. J Control Release. 2019 Feb 28;296:179-189.|[2]Daull P, et al. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema. J Ocul Pharmacol Ther. 2013 Mar;29 (2) :258-69.